KindlyMD, Inc. (NASDAQ:NAKA) Receives Consensus Recommendation of “Hold” from Analysts

KindlyMD, Inc. (NASDAQ:NAKA) has been assigned an average recommendation of “Hold” from the five brokerages that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $30.00.

NAKA has been the topic of a number of analyst reports. Maxim Group dropped their price target on KindlyMD from $60.00 to $30.00 and set a “buy” rating on the stock in a research note on Monday, April 6th. TD Cowen assumed coverage on shares of KindlyMD in a research note on Friday, April 10th. They set a “buy” rating and a $40.00 price objective for the company. Weiss Ratings upgraded shares of KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. Finally, Wall Street Zen raised shares of KindlyMD to a “sell” rating in a research report on Saturday, May 23rd.

KindlyMD Stock Up 2.3%

Shares of NASDAQ NAKA opened at $4.06 on Friday. The stock has a market capitalization of $70.64 million, a price-to-earnings ratio of -0.09 and a beta of 16.05. The stock’s fifty day simple moving average is $4.92 and its 200 day simple moving average is $9.29. KindlyMD has a 52-week low of $3.33 and a 52-week high of $659.20.

KindlyMD (NASDAQ:NAKA) last announced its earnings results on Wednesday, May 13th. The company reported ($0.38) EPS for the quarter. KindlyMD had a negative net margin of 7,397.12% and a negative return on equity of 81.32%. The company had revenue of $2.68 million for the quarter. As a group, analysts anticipate that KindlyMD will post -16.8 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO David F. Bailey acquired 104,833 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The stock was purchased at an average price of $4.84 per share, with a total value of $507,391.72. Following the purchase, the chief executive officer owned 3,120,361 shares of the company’s stock, valued at approximately $15,102,547.24. This trade represents a 3.48% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last three months, insiders have purchased 191,448 shares of company stock valued at $992,908. Company insiders own 24.49% of the company’s stock.

Institutional Trading of KindlyMD

Several large investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC lifted its stake in KindlyMD by 76.2% in the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock worth $484,000 after acquiring an additional 8,386 shares in the last quarter. Osaic Holdings Inc. purchased a new position in KindlyMD during the 2nd quarter valued at about $215,000. Tower Research Capital LLC TRC increased its holdings in shares of KindlyMD by 1,638.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 33,152 shares of the company’s stock valued at $827,000 after purchasing an additional 31,245 shares during the period. Victory Capital Management Inc. acquired a new position in shares of KindlyMD in the 3rd quarter valued at about $1,007,000. Finally, Sagespring Wealth Partners LLC purchased a new stake in shares of KindlyMD in the fourth quarter worth approximately $28,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.